MARATTO

article · Designed Monomers & Polymers

Advances in bio-polymer coatings for probiotic microencapsulation: chitosan and beyond for enhanced stability and controlled release

202450 citationsOpen accessDelta State University

In plain language

Bio-polymer coatings for probiotic microencapsulation enhance bacterial survival through processing, storage, and gastrointestinal transit to ensure effective gut delivery. Chitosan serves as a primary coating material, frequently combined with other bio-polymers such as alginate, gelatin, and pectin. Processing approaches including nanotechnology, spray drying, and layer-by-layer assembly improve these protective systems. In addition to delivering physical protection, chitosan acts functionally as a prebiotic or synbiotic by encouraging beneficial gut microbes and suppressing harmful pathogens. It also modulates immune signalling pathways, demonstrating potential therapeutic value in managing inflammatory bowel disease and autoimmune disorders. Evaluated across recent clinical trials and animal models, chitosan-coated probiotics offer real-world relevance for gut microbiota health, systemic immunity, and gut-brain axis interactions, while relying on sustainable sourcing.

Key takeaways

  • Combining chitosan with bio-polymers such as alginate, gelatin, and pectin improves probiotic stability during processing, storage, and gastrointestinal transit.
  • Techniques such as spray drying, nanotechnology, and layer-by-layer assembly facilitate the targeted delivery of probiotics to the gut.
  • Chitosan functions as a prebiotic or synbiotic material by promoting beneficial gut bacteria and inhibiting pathogens.
  • Chitosan-based formulations exhibit immunomodulatory effects with relevance to inflammatory bowel disease and autoimmune disorders.
  • Clinical trials and in vivo studies demonstrate practical health impacts, connecting gut microbiota changes to systemic immunity and the gut-brain axis.

Why it matters

Probiotics offer valuable health benefits, yet ensuring live bacteria survive food processing and stomach acid to reach the intestine remains difficult. Protective bio-polymer coatings address this issue while simultaneously contributing active health properties. Refining these materials allows manufacturers to deliver stable, viable probiotic treatments capable of supporting gut health, regulating immune function, and potentially addressing chronic inflammatory conditions.

Commercialisation angle

This work informs product development for functional food manufacturers, nutraceutical companies, and pharmaceutical developers focused on gastrointestinal and autoimmune treatments. The inclusion of industrial techniques like spray drying and evidence from human clinical trials indicates applied and near-market readiness for basic encapsulation. However, advanced applications such as personalised probiotic therapies and novel bio-polymer blends remain at an earlier research and development stage.

AI-generated from the published abstract. Always read the original work before citing.

Abstract

This review paper analyzes recent advancements in bio-polymer coatings for probiotic microencapsulation, with a particular emphasis on chitosan and its synergistic combinations with other materials. Probiotic microencapsulation is essential for protecting probiotics from environmental stresses, enhancing their stability, and ensuring effective delivery to the gut. The review begins with an overview of probiotic microencapsulation, highlighting its significance in safeguarding probiotics through processing, storage, and gastrointestinal transit. Advances in chitosan-based encapsulation are explored, including the integration of chitosan with other bio-polymers such as alginate, gelatin, and pectin, as well as the application of nanotechnology and innovative encapsulation techniques like spray drying and layer-by-layer assembly. Detailed mechanistic insights are integrated, illustrating how chitosan influences gut microbiota by promoting beneficial bacteria and suppressing pathogens, thus enhancing its role as a prebiotic or synbiotic. Furthermore, the review delves into chitosan's immunomodulatory effects, particularly in the context of inflammatory bowel disease (IBD) and autoimmune diseases, describing the immune signaling pathways influenced by chitosan and linking gut microbiota changes to improvements in systemic immunity. Recent clinical trials and human studies assessing the efficacy of chitosan-coated probiotics are presented, alongside a discussion of practical applications and a comparison of in vitro and in vivo findings to highlight real-world relevance. The sustainability of chitosan sources and their environmental impact are addressed, along with the novel concept of chitosan's role in the gut-brain axis. Finally, the review emphasizes future research needs, including the development of personalized probiotic therapies and the exploration of novel bio-polymers and encapsulation techniques.

Research topics

  • Probiotics and Fermented Foods
  • Gut microbiota and health
  • Advanced Drug Delivery Systems

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1080/15685551.2024.2448122

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.